An epidermal growth factor derivative with binding affinity for hydroxyapatite and titanium surfaces.

Area of Science:

• Biomaterials Science
• Cell Biology
• Protein Engineering

Background:

• Developing biomaterials that promote cell growth is crucial for tissue regeneration.
• Surface modification of biomaterials can enhance cellular response and integration.
• Epidermal Growth Factor (EGF) is a key mitogen for cell proliferation.

Purpose of the Study:

• To design and synthesize a novel EGF derivative with enhanced affinity for biomaterial surfaces.
• To evaluate the impact of this modified EGF on cell growth and signal transduction on hydroxyapatite and titanium.

Main Methods:

• A peptide moiety from salivary statherin, known for hydroxyapatite adhesion, was incorporated into EGF.
• Organic synthesis was used to create the 54-residue modified EGF peptide.
• Circular dichroism spectroscopy assessed conformational changes.
• Binding affinity, mitogenic activity, and cell growth on biomaterials were measured.

Main Results:

• The modified EGF exhibited significantly higher binding affinity to hydroxyapatite and titanium compared to unmodified EGF.
• Conformation and mitogenic activity of EGF were largely preserved after modification.
• The modified EGF significantly enhanced cell growth on hydroxyapatite and titanium surfaces.
• Bound EGF prolonged intracellular signal transduction compared to unbound EGF.

Conclusions:

• A novel EGF derivative with enhanced surface affinity for biomaterials was successfully synthesized.
• The modified EGF promotes enhanced cell proliferation and sustained signaling on hydroxyapatite and titanium.
• This engineered EGF holds potential for improving osseointegration and regenerative applications.